Kallikrein 4 Antikörper (AA 242-254)
Kurzübersicht für Kallikrein 4 Antikörper (AA 242-254) (ABIN636259)
Target
Alle Kallikrein 4 (KLK4) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 242-254
-
Aufreinigung
- Affinity chromatography purified
-
Immunogen
- KLK-L1 antibody was raised in rabbit using AA 242-254 [KFTEWIEKTVQAS] of the human 39 kDa KLK-L1 (KLK4) protein as the immunogen.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- Lot specific
-
Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- Kallikrein 4 (KLK4) (Kallikrein-Related Peptidase 4 (KLK4))
-
Andere Bezeichnung
- KLK-L1
-
Hintergrund
- Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis. A novel Kallikrein gene Prostase/KLK-L1 (also known as KLK4) is expressed and is up-regulated by androgens and progestins. KLK-L1 may be involved in the pathogenesis and/or progression of prostate, breast, and possibly other malignancies.
-
Pathways
- Komplementsystem
Target
-